相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evolution of oncolytic adenovirus for cancer treatment
Joung-Woo Choi et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF
K-J Choi et al.
GENE THERAPY (2012)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
I-K Choi et al.
GENE THERAPY (2011)
A Novel Combination Treatment of Armed Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Radiotherapy in Murine Hepatocarcinoma
Wonwoo Kim et al.
JOURNAL OF RADIATION RESEARCH (2011)
Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
Sari Pesonen et al.
MOLECULAR PHARMACEUTICS (2011)
Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
Song-Nan Zhang et al.
MOLECULAR THERAPY (2011)
Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis
J-N Zheng et al.
CANCER GENE THERAPY (2010)
Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy
Tsuguhide Takeshima et al.
CANCER RESEARCH (2010)
Oncolytic (replication-competent) adenoviruses as anticancer agents
Karoly Toth et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
A. Danielsson et al.
GENE THERAPY (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
Massimo Di Nicola et al.
BLOOD (2009)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Youjin Lee et al.
BLOOD (2009)
A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor Armed oncolytic adenovirus for the treatment of head and neck cancers
Jianhua Chang et al.
CANCER BIOLOGY & THERAPY (2009)
Armed replicating adenoviruses for cancer virotherapy
J. J. Cody et al.
CANCER GENE THERAPY (2009)
Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
Edukulla Ramakrishna et al.
CANCER RESEARCH (2009)
Cytokine gene-mediated immunotherapy: Current status and future perspectives
Masahisa Jinushi et al.
CANCER SCIENCE (2009)
A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients
J-L Li et al.
GENE THERAPY (2009)
Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity
Natalia Lapteva et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
Sergia Bortolanza et al.
MOLECULAR THERAPY (2009)
Radiation-induced bystander signalling in cancer therapy
Kevin M. Prise et al.
NATURE REVIEWS CANCER (2009)
T-cell responses to survivin in cancer patients undergoing radiation therapy
Doerthe Schaue et al.
CLINICAL CANCER RESEARCH (2008)
Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis
W. Qian et al.
LEUKEMIA (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Interleukin-12: Biological properties and clinical application
Michele Del Vecchio et al.
CLINICAL CANCER RESEARCH (2007)
Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4
Dawn E. Post et al.
CANCER RESEARCH (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Targeting interferon-α increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus
Elena V. Shashkova et al.
MOLECULAR THERAPY (2007)
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta-Chiang Liu et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Cancer selective adenoviruses
Ramon Alemany
MOLECULAR ASPECTS OF MEDICINE (2007)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-γ gene yields efficient antitumor activity in immunodeficient and immunocompetent mice
Changqing Su et al.
MOLECULAR THERAPY (2006)
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant
Willem W. Overwijk et al.
JOURNAL OF IMMUNOLOGY (2006)
Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo
M Le Borgne et al.
IMMUNITY (2006)
Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses
NC Di Paolo et al.
CANCER RESEARCH (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas
L. Barzon et al.
CANCER GENE THERAPY (2006)
Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer
LL Zhao et al.
HUMAN GENE THERAPY (2005)
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor
AA Lugade et al.
JOURNAL OF IMMUNOLOGY (2005)
Use of replicating oncolytic adenoviruses in combination therapy for cancer
RL Chu et al.
CLINICAL CANCER RESEARCH (2004)
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors:: Role for CD8+ T cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2004)
Overview of interleukin-2 function, production and clinical applications
SL Gaffen et al.
CYTOKINE (2004)
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines
SM Sumida et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination
J Galea-Lauri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Facets of heat shock protein 70 show immunotherapeutic potential
SM Todryk et al.
IMMUNOLOGY (2003)
Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer Xenografts
M Zhang et al.
MOLECULAR THERAPY (2003)
In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF
JA Bristol et al.
MOLECULAR THERAPY (2003)
Multigene expression from a replicating adenovirus using native viral promoters
M Bauzon et al.
MOLECULAR THERAPY (2003)
Survival of patients with metastatic breast carcinoma - Importance of prognostic markers of the primary tumor
J Chang et al.
CANCER (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes
TW Hermiston et al.
CANCER GENE THERAPY (2002)
Analysis of the immunologic response generated by Ad.IFN-β during successful intraperitoneal tumor gene therapy
M Odaka et al.
MOLECULAR THERAPY (2002)
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
M Ratta et al.
BLOOD (2002)
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region
LK Hawkins et al.
GENE THERAPY (2001)
In situ gene therapy for prostate cancer:: immunomodulatory approaches
TC Thompson et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015):: results of Phase I and II trials
D Kirn
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
D Kirn
GENE THERAPY (2001)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine
A Asea et al.
NATURE MEDICINE (2000)
Alteration of tumour response to radiation by interleukin-2 gene transfer
J Lee et al.
BRITISH JOURNAL OF CANCER (2000)
The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2000)